Stability of miRNA in human urine supports its biomarker potential

Biomarkers in Medicine

Volumn 7, Issue 4, 2013, Pages 623-631

  Mall, Christine ^a,b   Rocke, David M ^a   Durbin Johnson, Blythe ^a   Weiss, Robert H ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

biomarkers; cancer; miRNA; stability; urine

Indexed keywords

MICRORNA; MICRORNA 16; MICRORNA 21; TRYPSIN;

ADULT; ARTICLE; CONCENTRATION RESPONSE; EXOSOME; FEMALE; FREEZING; GENE AMPLIFICATION; HUMAN; MALE; NORMAL HUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA DEGRADATION; RNA STABILITY; ROOM TEMPERATURE; STORAGE TEMPERATURE; THAWING; URINALYSIS;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; KIDNEY DISEASES; LIMIT OF DETECTION; MALE; MICRORNAS; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RNA STABILITY; SPECIMEN HANDLING; TRYPSIN;

EID: 84881298463     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.13.44     Document Type: Article

References (39)

1. Catto JW, Alcaraz A, Bjartell AS et al. MicroRNA in prostate, bladder, and kidney cancer: A systematic review. Eur. Urol. 59, 671-681 (2011
2. Trang P, Weidhaas JB, Slack FJ. MicroRNAs as potential cancer therapeutics. Oncogene 27(Suppl. 2), S52-S57 (2008
3. Kato M, Park JT, Natarajan R. MicroRNAs and the glomerulus. Exp. Cell. Res. 318, 993-1000 (2012
4. Macconi D, Tomasoni S, Romagnani P et al. MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition. J. Am. Soc. Nephrol. 23, 1496-1505 (2012
5. Weber JA, Baxter DH, Zhang S et al. The microRNA spectrum in 12 body fluids. Clin. Chem. 56, 1733-1741 (2010
6. Hanke M, Hoefig K, Merz H et al. A robust methodology to study urine microRNA as tumor marker: MicroRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol. Oncol. 28, 655-661 (2010
7. Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT PCR). Methods 50, 298-301 (2010
8. Mitchell PS, Parkin RK, Kroh EM et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA 105, 10513-10518 (2008
9. Taylor SL, Ganti S, Bukanov NO et al. A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. Am. J. Physiol. Renal Physiol. 298, F909-F922 (2010
10. Ganti S, Taylor S, Kim K et al. Urinary acylcarnitines are altered in kidney cancer. Int. J. Cancer 130(12), 2791-2800 (2012
11. Kim K, Taylor SL, Ganti S, Guo L, Osier MV, Weiss RH. Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. OMICS 15, 293-303 (2011
12. Miranda KC, Bond DT, McKee M et al. Nucleic acids within urinary exosomes/ microvesicles are potential biomarkers for renal disease. Kidney Int. 78, 191-199 (2010
13. Yamada Y, Enokida H, Kojima S et al. miR 96 and miR 183 detection in urine serve as potential tumor markers of urothelial carcinoma: Correlation with stage and grade, and comparison with urinary cytology. Cancer Sci. 102, 522-529 (2011
14. Wang G, Tam LS, Kwan BC et al. Expression of miR 146a and miR 155 in the urinary sediment of systemic lupus erythematosus. Clin. Rheumatol. 31, 435-440 (2012
15. Wang G, Kwan BC, Lai FM, Chow KM, Li PK, Szeto CC. Elevated levels of miR 146a and miR 155 in kidney biopsy and urine from patients with IgA nephropathy. Dis. Markers 30, 171-179 (2011
16. Scian MJ, Maluf DG, David KG et al. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am. J. Transplant. 11, 2110-2122 (2011
17. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N. Plasma miR 208 as a biomarker of myocardial injury. Clin. Chem. 55, 1944-1949 (2009
18. Kwok PY, Gu Z. Single nucleotide polymorphism libraries: Why and how are we building them? Mol. Med. Today 5, 538-543 (1999
19. Gonzales PA, Zhou H, Pisitkun T et al. Isolation and purification of exosomes in urine. Methods Mol. Biol. 641, 89-99 (2010
20. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007
21. Juan D, Alexe G, Antes T et al. Identification of a microRNA panel for clear-cell kidney cancer. Urology 75, 835-841 (2010
22. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 11, 426-437 (2011
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25, 402-408 (2001
24. Brow DA, Guthrie C. Spliceosomal RNA U6 is remarkably conserved from yeast to mammals. Nature 334, 213-218 (1988
25. MicroRna Profiling in Cancer: A Bioinformatics Perspective. Gusev Y (Ed.). Pan Stanford Publishing, Singapore (2010
26. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids-The mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 8, 467-477 (2011
27. Mathivanan S, Ji H, Simpson RJ. Exosomes: Extracellular organelles important in intercellular communication. J. Proteomics 73, 1907-1920 (2010
28. Minamida S, Iwamura M, Kodera Y et al. 14-3-3 protein beta/alpha as a urinary biomarker for renal cell carcinoma: Proteomic analysis of cyst fluid. Anal. Bioanal. Chem. 401, 245-252 (2011
29. Yokomizo A, Takakura M, Kanai Y, Sa et al. Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney. Cancer Biomark. 10, 175-183 (2011
30. Heneghan HM, Miller N, Kerin MJ. MiRNAs as biomarkers and therapeutic targets in cancer. Curr. Opin. Pharmacol. 10, 543-550 (2010
31. White NM, Khella HW, Grigull J et al. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR 215. Br. J. Cancer 105, 1741-1749 (2011
32. Ho AS, Huang X, Cao H et al. Circulating miR 210 as a novel hypoxia marker in pancreatic cancer. Transl. Oncol. 3, 109-113 (2010
33. Camps C, Buffa FM, Colella S et al. Hsa miR 210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res. 14, 1340-1348 (2008
34. Fasanaro P, D'Alessandra Y, Di SV et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 283, 15878-15883 (2008
35. Wang G, Kwan BC, Lai FM, Chow KM, Kam-Tao LP, Szeto CC. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Dis. Markers 28, 79-86 (2010
36. Lorenzen JM, Volkmann I, Fiedler J et al. Urinary miR 210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Am. J. Transplant. 11(10), 2221-2227 (2011
37. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433 (2011
38. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233 (2011
39. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc. Natl Acad. Sci. USA 101, 13368-13373 (2004